Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Cosmetics

  • Print
  • Share
  • E-mail
-

BSE and Cosmetics: FDA Risk Assessment and Management Perspectives

December 7, 2006

Also available as a PowerPoint presentation

Author: Stanley R. Milstein, Ph.D.

Table of Contents
  1. BSE and Cosmetics: FDA Risk Assessment and Management Perspectives
  2. Mad Cow Disease
  3. Cosmetic and Color Additive Regulatory Requirements
  4. OCAC's Top Risk-Based Enforcement Priorities
  5. BSE and FDA Oversight of Cosmetics
  6. Cosmetics and BSE/v-CJD
  7. Ingredients from the CTFA Cosmetic Ingredient Dictionary (6th Edition) that are from "Bovine" or "Animal" Sources
  8. Ingredients from the CTFA Cosmetic Ingredient Dictionary (6th Edition) that are from "Bovine" or "Animal" Sources (continued)
  9. Ingredients from the CTFA Cosmetic Ingredient Dictionary (6th Edition) that are from "Bovine" or "Animal" Sources (continued)
  10. Ingredients from the CTFA Cosmetic Ingredient Dictionary (6th Edition) that are from "Bovine" or "Animal" Sources (continued)
  11. BSE
  12. Specified Risk Materials (SRMs)
  13. Tallow - Cosmetic Functions
  14. Frequency of Use by Chemical Name
  15. Animal (Potential BSE) Ingredients - FoU Update: 2002 vs. 2004
  16. Animal (Potential BSE) Ingredients - FoU Update: 2002 vs. 2004
  17. Animal (Potential BSE) Ingredients - FoU Update: 2002 vs. 2004
  18. Gelatin - Cosmetic Functions
  19. Gelatin - 57 Cosmetic Product Registrations {FDA VCRP Data, 21 CFR 720.4; May 2003}
  20. Gelatin - Cosmetic Ingredients
  1. Lytic Agent
  2. Oral Health Care Drugs (CTFA, ICID-9)
  3. Regulatory Coverage of Ruminant Tissues and Tissue Derived Ingredients
  4. Use of Material Derived from Cattle in Cosmetics
  5. BSE/ v-CJD: OCAC Role In Process of BSE Risk Analysis- I
  6. BSE/ v-CJD: OCAC Role In Process of BSE Risk Analysis- II
  7. Industry Initiatives
  8. BSE/ v-CJD: OCAC Role In Process of BSE Risk Analysis- III
  9. Bovine Spongiform Encephalopathy (BSE)
  10. Use of Material Derived From Cattle in Cosmetics
  11. 2005 Amendments to BSE Interim Final Rule (IFR)
  12. Proposed Record-Keeping for Cosmetics With Cattle Material
  13. Record-Keeping
  14. FDA Export Certificates
  15. BSE Export Certificates
  16. BSE Risk Assessment
  17. BSE Risk Assessment: Framework
  18. BSE Risk Assessment
  19. BSE Risk Assessment-1
  20. BSE Risk Assessment-2
  21. BSE Risk Assessment
  22. Recent BSE Cases in North America: January 23, 2006; March 13, 2006
  23. v-CJD Cases in the U.S.
  24. FDA Export Certificates
  25. CFSAN-OCAC Address Information
-
-